AstraZeneca
1,515
SEK
-0.46 %
AZN
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
-0.46%
+2.71%
+4.74%
-1.05%
-11.56%
+9.78%
+47.09%
+60.85%
+8,189.79%
AstraZeneca is a global biopharmaceutical company that focuses on the research, development, and marketing of prescription drugs, primarily for the treatment of diseases in the areas of therapy that affect the respiratory tract, cardiovascular / metabolism, and cancer. In addition to its main operations, the company is also active in autoimmunity, neuroscience, and infection. AstraZeneca is active in all global regions and is headquartered in Cambridge.
Read moreMarket cap
2.35T SEK
Turnover
234.76M SEK
Revenue
462.19B
EBIT %
17.88 %
P/E
39.11
Dividend yield-%
1.93 %
Financial calendar
6.2
2025
Annual report '24
29.4
2025
Interim report Q1'25
ShowingAll content types
AstraZeneca: Notice of AGM
AstraZeneca: Filing of Form 20-F with SEC
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools